New ALS guideline establishes national standard for managing neurodegenerative disease

The first Canadian guideline for the care and management of patients with amyotrophic lateral sclerosis (ALS) — Lou Gehrig’s disease — recommends a patient-focused approach, with attention to holistic and emotional aspects of well-being. The guideline, published in CMAJ (Canadian Medical Association Journal), is intended for ALS clinicians, allied health professionals and primary care providers, […]

Investigational ALS drug prolongs patient survival in clinical trial — ScienceDaily

An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, has now demonstrated the potential to also prolong patient survival. The findings come from a clinical trial conducted by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts […]